Janice Post-White

Janice Post-White

Auto-generated profile, based on publicly available information

Janice Post-White

University of Minnesota Twin Cities, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2011 in Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
CLCecile A. Lengacher
Cecile A. Lengacher
RRRichard R. Reich
Richard R. Reich
JPJanice Post-White
Janice Post-White
MMManolete Moscoso
Manolete Moscoso
MSMelissa M. Shelton
Melissa M. Shelton
PBPinky Budhrani
Pinky Budhrani

5 August 2018 in Biological Research For Nursing
Verified
Journal Article
Closed access
CLCecile A. Lengacher
Cecile A. Lengacher
RRRichard R. Reich
Richard R. Reich
CPCarly L. Paterson
Carly L. Paterson
MSMelissa Shelton
Melissa Shelton
SSSteve Shivers
Steve Shivers
JPJong Y. Park
Jong Y. Park
Breast cancer survivors (BCS) often experience psychological and physiological symptoms after cancer treatment. Mindfulness-based stress reduction (MBSR), a complementary and alternative therapy, has reduced subjective measures of stress, anxiety, and fatigue among BCS. Little is known, however, about how MBSR affects objective markers of stress, specifically the stress hormone cortisol and the pro-inflammatory cytokine interleukin-6 (IL-6). In the present study, BCS (N = 322) were randomly assigned to a 6-week MBSR program for BC or usual-care control. Measurements of cortisol, IL-6, symptoms, and quality of life were obtained at orientation and 6 weeks. Cortisol and IL-6 were also measured prior to and after the MBSR(BC) class Weeks 1 and 6. The mean age of participants was 56.6 years and 69.4% were White non-Hispanic. Most had Stage I (33.8%) or II (35.7%) BC, and 35.7% had received chemotherapy and radiation. Cortisol levels were reduced immediately following MBSR(BC) class compared to before the class Weeks 1 and 6 (Wilcoxon-signed rank test; p < .01, d = .52–.56). IL-6 was significantly reduced from pre- to postclass at Week 6 (Wilcoxon-signed rank test; p < .01, d = .21). No differences were observed between the MBSR(BC) and control groups from baseline to Week 6 using linear mixed models. Significant relationships with small effect sizes were observed between IL-6 and both symptoms and quality of life in both groups. Results support the use of MBSR(BC) to reduce salivary cortisol and IL-6 levels in the short term in BCS.

1 January 2010
Verified
Dataset
Closed access
CLCecile Lengacher
Cecile Lengacher
RRRichard Reich
Richard Reich
JPJanice Post-White
Janice Post-White
MBMichelle Barta
Michelle Barta
MSMelissa Shelton
Melissa Shelton
PBPinky Budhrani
Pinky Budhrani